The second most common HER3 mutation seen in bladder cancer is V104M/L/Wfs*18, where the valine (V) at the 104th amino acid position is changed to either a methionine (M) or leucine (L) or involved in a frame shift deletion (Figure 3). Here, ERBB3 is linked to urinary bladder carcinoma.